Literature DB >> 16076530

Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.

Kenji Hikosaka1, Masaaki Satoh, Yukari Koyama, Yutaka Nakai.   

Abstract

Doses of 1-10(5) oocysts of Cryptosporidium parvum HNJ-1 were inoculated into severe combined immunodeficient (SCID) mice, and the discharge of oocysts was monitored for 30 days post inoculation. None of the mice discharged any oocysts after oral inoculation of one oocyst. Only one of five SCID mice discharged oocysts after oral inoculation of 10 oocysts, and the prepatent period was 17 days. The other four mice did not discharge any oocysts. All the SCID mice discharged oocysts after oral inoculation of 10(2)-10(5) oocysts. The prepatent periods were 13-17, 8-10, 8, and 10 days in SCID mice inoculated with 10(2), 10(3), 10(4), and 10(5) oocysts, respectively. A proportional correlation was observed between inoculation doses of oocysts ranging from 10 to 10(4) oocysts and the corresponding prepatent periods. The prepatent period can be used to evaluate the infectivity of C. parvum oocysts.

Entities:  

Mesh:

Year:  2005        PMID: 16076530     DOI: 10.1016/j.vetpar.2005.06.017

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

1.  Individual subject meta-analysis of parameters for Cryptosporidium parvum shedding and diarrhoea in animal experimental models.

Authors:  A D Adell; W A Miller; D J Harvey; E Vanwormer; S Wuertz; P A Conrad
Journal:  Epidemiol Infect       Date:  2012-10-16       Impact factor: 4.434

Review 2.  Assessing viability and infectivity of foodborne and waterborne stages (cysts/oocysts) of Giardia duodenalis, Cryptosporidium spp., and Toxoplasma gondii: a review of methods.

Authors:  Angélique Rousseau; Stéphanie La Carbona; Aurélien Dumètre; Lucy J Robertson; Gilles Gargala; Sandie Escotte-Binet; Loïc Favennec; Isabelle Villena; Cédric Gérard; Dominique Aubert
Journal:  Parasite       Date:  2018-03-19       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.